Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Clinical trial NCT00448539 · TERMINATED

Trial details

NCT number: NCT00448539
Sponsor: Eisai Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Refractory Partial Onset Seizures

Start date: 2007-03-15
Primary completion: 2010-05-14
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.